Similar articles

• Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.

  [No authors listed] [No authors listed] Am J Ophthalmol. 1999 May;127(5):537-44. doi: 10.1016/s0002-9394(99)00034-3. Am J Ophthalmol. 1999. PMID: 10334346 Clinical Trial.
• Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.

  Lane SS, Holland EJ. Lane SS, et al. J Cataract Refract Surg. 2013 Feb;39(2):168-73. doi: 10.1016/j.jcrs.2012.10.039. Epub 2012 Dec 8. J Cataract Refract Surg. 2013. PMID: 23232255 Clinical Trial.
• Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.

  Howes JF, Baru H, Vered M, Neumann R. Howes JF, et al. J Ocul Pharmacol. 1994 Spring;10(1):289-93. doi: 10.1089/jop.1994.10.289. J Ocul Pharmacol. 1994. PMID: 8207332
• Treatment of ocular inflammatory conditions with loteprednol etabonate.

  Pavesio CE, Decory HH. Pavesio CE, et al. Br J Ophthalmol. 2008 Apr;92(4):455-9. doi: 10.1136/bjo.2007.132621. Epub 2008 Feb 1. Br J Ophthalmol. 2008. PMID: 18245274 Review.
• Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.

  Amon M, Busin M. Amon M, et al. Int Ophthalmol. 2012 Oct;32(5):507-17. doi: 10.1007/s10792-012-9589-2. Epub 2012 Jun 16. Int Ophthalmol. 2012. PMID: 22707339 Free PMC article. Review.